Duration of Anticoagulation for Venous Thromboembolic Events

Content Provider	Scilit
Author	Smilowitz, Nathaniel R. Mega, Jessica L. Berger, Jeffrey S.
Copyright Year	2014
Description	Journal: Circulation A 68 year-old woman with a history of hypertension, hyperlipidemia, and diverticulitis presents to your office for follow-up care. Three months ago, she developed 3 days of pain and swelling in her right calf and thigh. Lower extremity venous ultrasonography demonstrated a deep vein thrombosis in the right femoral vein. No identifiable cause was noted. She was started on therapeutic enoxaparin as a bridge to warfarin anticoagulation for idiopathic venous thromboembolism. Since discharge, her international normalized ratio (INR) has been maintained between 2 and 3. She has no history of prior bleeding or thromboembolic events. She wants to know how long to continue anticoagulation, and what she can do to minimize her risk of recurrent venous thromboembolism.
Related Links	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279444/pdf https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.114.010456
Ending Page	2348
Page Count	6
Starting Page	2343
ISSN	00097322
e-ISSN	15244539
DOI	10.1161/circulationaha.114.010456
Journal	Circulation
Issue Number	25
Volume Number	130
Language	English
Publisher	Ovid Technologies (Wolters Kluwer Health)
Publisher Date	2014-12-01
Access Restriction	Open
Subject Keyword	Journal: Circulation Emergency Medicine Venous Thromboembolism Deep Vein Thrombosis Pulmonary Embolism Extended Duration
Content Type	Text
Resource Type	Article
Subject	Physiology (medical) Cardiology and Cardiovascular Medicine